Anlotinib enhanced CD8+ T cell infiltration via induction of CCL5 improves the efficacy of PD-1/PD-L1 blockade therapy in lung cancer
J Luo, K Cheng, X Ji, C Gao, R Zhu, J Chen, W Xue… - Cancer Letters, 2024 - Elsevier
Non-small cell lung cancer (NSCLC) is a leading cause of mortality worldwide and requires
effective treatment strategies. Recently, the development of a novel multiple-target tyrosine …
effective treatment strategies. Recently, the development of a novel multiple-target tyrosine …